Makita, S., Maruyama, D., & Tobinai, K. (2020). Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma. Onco Targets Ther.
Citación estilo ChicagoMakita, Shinichi, Dai Maruyama, and Kensei Tobinai. "Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma." Onco Targets Ther 2020.
Cita MLAMakita, Shinichi, Dai Maruyama, and Kensei Tobinai. "Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma." Onco Targets Ther 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.